Needles Market by Type (Conventional (Bevel, Vented) & Safety), Product (Suture, Blood Collection, Insufflation), Material (Stainless Steel, Plastic), Delivery Mode (IV, IM, Hypodermic), End-User (Hospitals, Diagnostic Centres) & Region - Global Forecast to 2027
Market Growth Outlook Summary
The global needles market growth forecasted to transform from billion USD 7.7 in 2022 to USD 10.6 billion by 2027, driven by a CAGR of 6.7%. The expansion of this market is majorly due to upsurging cases of chronic diseases such as cancer, HIV as well as growing elderly population. However, Growing focus on core development of substitute drug delivery methods is one of the challenge for which may inhibit the growth of this market.
Needles Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Global Needles Market Dynamics
Drivers: Increasing number of hospitals in emerging markets
The number of hospitals and surgical centers is increasing in both developed and emerging countries. The demand for medical or surgical devices (including blood collection devices) is high in these newly established surgical centers and hospitals, owing to the increasing patient population base. For instance, in October 2020, the Prime Minister of the UK announced plans of investing USD 4.3 billion for 40 hospitals and certain schemes for future funding for 48 hospitals by 2030. In addition, in March 2021, Steward Health Care announced plans to construct a new hospital in Washington County.
Over the last decade, developing countries, such as India and China, have witnessed significant improvements in their respective healthcare infrastructure. According to an article published in January 2020, China announced to invest USD 4.6 billion for the construction of hospitals in Wuhan. According to the Commonwealth Fund in 2018, China has approximately 12,000 public hospitals and 21,000 private hospitals. Similarly, in June 2019, the Indian Ministry of Health and Family Welfare announced the opening of 22 new AIIMS across the country. The significant growth in the number of hospitals and surgical centers is expected to support the growth of the needles market.
Opportunities: Rise in self-administration of drugs
The adoption of self-administration of drugs by patients has led to the rise in demand for self-administered injectables, which are easy to use. These self-injecting devices are most used for the treatment of emergency conditions such as allergies or chronic diseases such as diabetes. The use of self-administering injectables helps in reducing the anxiety caused by needles among users.
Self-administration of injectable contraceptives is widely adopted among females to avoid the expense and inconvenience of visits to the clinic. Injectable contraceptives are safer than other contraceptives. They prevent pregnancy 99% of the time when administered correctly. These injections also provide protection against cancer of the womb and pelvic inflammatory diseases, and it can be administered during the menstrual cycle as well.
These self-administered injections are a preferred option for patients suffering from diabetes, breast cancer, liver tumours, or osteoporosis. In line with this, companies are focusing on developing novel self-administration devices.
With the growing adoption of self-administering injectables, the demand for needles will increase, which would contribute to the growth of this market across the globe.
Challenges: Growing focus on the development of alternative drug delivery methods
Traditionally, injectables were invasive and painful, which was the major reason for patients to prefer alternate routes of drug delivery, such as oral, topical, and nasal. Among the various routes of drug delivery, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable. Owing to the abovementioned factors, the adoption of alternative drug delivery technologies is increasing across the globe. For instance, the development of alternate delivery methods for insulin, such as Pfizer’s Exubera (inhaled insulin) and Veo insulin pump (Medtronic’s inhalable insulin), is limiting the use of injectable insulin. Currently, insulin injections form a significant market for injectable drug delivery technologies. However, the advent of inhalable insulin will negatively impact this market as nasal drug delivery is pain-free and highly patient compliant. The development of alternate delivery techniques such as oral anemia treatment (by GlaxoSmithKline and Bayer) is also hampering the need for needles.
Due to their large molecular size and stability issues, proteins and peptides have been traditionally administered by the injectable route of drug delivery. However, smaller molecules of peptides have been developed recently through complex methods such as nanotechnology, allowing for oral administration of therapeutic proteins and peptides.
China is anticipated to account the largest share of Apac Needles Market
Based on the Apac region, the Needles Market is divided into China, Japan, and India. China is expected to account the largest share of Needles Market. The increasing demand for blood components (owing to the rising number of surgical procedures and the high prevalence of various diseases, inclusive of blood disorders) requiring diagnostic blood tests, growing awareness about therapeutic apheresis, and rising demand for plasma derivatives are the major factors supporting the growth of the Needles Market in China.
Germany is forecasted as the fastest growing country of Needles Market in Europe.
Based on the Europe region, the Needles Market is divided into Germany, UK, Italy, Spain, France, and RoE. Germany is forecasted to the fastest growing market of Needles Market in Europe. The increasing incidence of neoplasm cases is the major factor driving the market for needles in the country.
North America dominates the global Needles Market
Based on the region, the Needles Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the Needles Market. Growth in the North American market is mainly driven by, increasing cases of severe diseases, and increasing heart diseases as well as medical procedures.
To know about the assumptions considered for the study, download the pdf brochure
Needles Market Key Players
Some of the players operating in North American market are Becton, Dickinson and Company (US), Stryker Corporation (US), Ethicon, Inc. (Subsidiary of Johnson and Johnson) (US), Olympus Corporation (US), Merit Medical (US), Hamilton Company (US) Unimed SA, Argon Medical Devices Inc. (US), Smiths Medical (US), Ultimed Inc. (US).
Needles Market Scope
|
Report Metric |
Details |
|
Market Size Available for Years |
2017–2027 |
|
Base Year Considered |
2021 |
|
Forecast Period |
2022–2027 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Product, Type, Application, Material, Delivery Mode, End User and Region. |
|
Geographies Covered |
North America (US, Canada), Europe (Germany, France, UK, Spain, Italy, and RoE), APAC (China, India, Japan, and the RoAPAC), and Rest of the World (Latin America, Middle East & Africa). |
|
Companies Covered |
Medtronic (Ireland), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Stryker Corporation (US), Ethicon, Inc. (Subsidiary of Johnson and Johnson) (US), Boston Scientific Corporation (US), Terumo Corporation (Japan), Olympus Corporation (US), Merit Medical (US), Greiner Holding AG (Austria), Merck KgA (Germany), Hamilton Company (US) Unimed SA, Argon Medical Devices Inc. (US), Nipro Corporation (Japan), Smiths Medical (US), Ultimed Inc. (US), Hakko Co.Ltd. (Japan), Creganna (Ireland), DTR Medical (UK), and Rocket Medical (UK) |
This research report categorizes the Needle Market into the following segments and subsegments:
By Regional Split
- North America
- Europe
- Asia Pacific
- Rest of the World
By Product
- Suture Needles
- Blood Collection Needles
- Ophthalmic Needles
- Dental Needles
- Insufflation Needles
-
Pen Needles
- Standard Needles
- Safety Needles
-
Biopsy and Aspiration Needles
- Biopsy Needles
- Core Biopsy Needles
- Vaccum Assisted Needles
- Aspiration Needles
- Other Needles
By Type
-
Conventional Needles
- Bevel Needles
- Blunt Fill Needles
- Vented Needles
- Filter Needles
-
Safety Needles
- Active Needles
- Passive Needles
By Application
- Diagnostic Applications
- Therapeutics Applications
By Delivery Mode
- Hypodermic Needles
- Intravenous Needles
- Intramuscular Needles
- Intraperitoneal Needles
By Material
- Glass Needles
- Plastic Needles
- Stainless Steel/Metallic Needles
- Polyetheretherketone (PEEK) Needles
By End User
- Hospitals and Clinics
- Diagnostic Centers
- Home Healthcare
- Other End Users
Recent Developments:
- In 2020, The company Becton, Dickinson and Company (US), entered into strategic partnership agreement with Babson Diagnostics (US) to bring laboratory-quality, small-volume blood collection to retail pharmacies.
- In 2021, The company Olympus Corporation (US), launched the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope for minimally invasive lung cancer diagnosis and staging via needle biopsy.
Frequently Asked Questions (FAQ):
What is the projected market value of the global Needles Market?
The global Needles Market is projected to reach USD 10.6 billion by 2027.
What is the estimated growth rate (CAGR) of the global Needles Market for the next five years?
The global Needles Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.7% from 2022 to 2027.
Who are the major players offering Needles in the market?
Becton, Dickinson, and Company (US), Medtronic (Ireland), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), and Stryker Corporation (US).
Which is the fastest growing region of the Needles Market for the next five years?
Asia Pacific is the fastest growing region for the Needles Market during the forecast period.
Which region will occupy most shares for the Needles Market for the next five years?
North America will have most shares for the Needles Market during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 20)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 GEOGRAPHIC SCOPE
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 24)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
FIGURE 5 REVENUE SHARE ANALYSIS
2.2.1 GROWTH FORECAST
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR STUDY
2.6 INDICATORS AND ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT
3 EXECUTIVE SUMMARY (Page No. - 36)
FIGURE 9 NEEDLES MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
FIGURE 10 NEEDLES MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION)
FIGURE 11 NEEDLES MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD BILLION)
FIGURE 12 NEEDLES MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
FIGURE 13 NEEDLES MARKET, BY END USER, 2022 VS. 2027 (USD BILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NEEDLES MARKET
4 PREMIUM INSIGHTS (Page No. - 40)
4.1 NEEDLES MARKET OVERVIEW
FIGURE 15 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
4.2 NORTH AMERICA: NEEDLES MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 16 CONVENTIONAL NEEDLES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4.3 NEEDLES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 42)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 High prevalence of chronic diseases
FIGURE 19 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION)
FIGURE 20 INCIDENCES OF DIABETES, 2021 VS. 2025 (MILLION)
5.2.1.2 Growing geriatric population
5.2.1.3 Rising number of accidents and trauma cases
5.2.1.4 Increasing number of hospitals in emerging markets
5.2.1.5 Increasing preference for minimally invasive biopsies
5.2.1.6 Increasing demand for vaccines
5.2.2 RESTRAINTS
5.2.2.1 Rising incidence of needlestick injuries and infections
5.2.2.2 Risk of infections associated with use of aspiration and biopsy needles
5.2.3 OPPORTUNITIES
5.2.3.1 Expanding injectables market
5.2.3.2 Rise in self-administration of drugs
5.2.3.3 Rising use of safety needles
5.2.3.4 Emerging markets
5.2.4 CHALLENGES
5.2.4.1 Use of needle-free injection technology
5.2.4.2 Growing focus on development of alternative drug delivery methods
5.3 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 22 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.5 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 INTENSITY OF COMPETITIVE RIVALRY
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 BARGAINING POWER OF SUPPLIERS
5.5.5 THREAT OF SUBSTITUTES
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
TABLE 2 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS (%)
5.6.2 BUYING CRITERIA
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 3 KEY BUYING CRITERIA FOR TOP THREE END USERS
5.7 REGULATORY LANDSCAPE
5.7.1 NORTH AMERICA
5.7.1.1 US
5.7.1.2 Canada
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.7.2 EUROPE
5.7.3 ASIA PACIFIC
5.7.3.1 Japan
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.7.3.2 China
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.7.3.3 India
5.8 TRADE ANALYSIS
TABLE 7 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 8 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2017–2021 (USD MILLION)
5.9 ECOSYSTEM ANALYSIS
TABLE 9 ROLE IN ECOSYSTEM
FIGURE 25 KEY PLAYERS OPERATING IN NEEDLES MARKET
5.1 PATENT ANALYSIS
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 10 LIST OF CONFERENCES AND EVENTS, 2022–2023
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE OF PRODUCTS, BY KEY PLAYER
TABLE 11 PRICE RANGE OF KEY PRODUCTS IN NEEDLES MARKET (USD)
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.14 TECHNOLOGY ANALYSIS
6 NEEDLES MARKET, BY PRODUCT (Page No. - 64)
6.1 INTRODUCTION
TABLE 12 NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 BLOOD COLLECTION NEEDLES
6.2.1 INCREASING NUMBER OF BLOOD COLLECTION PROCEDURES TO DRIVE MARKET
TABLE 13 EXAMPLES OF BLOOD COLLECTION NEEDLES
TABLE 14 BLOOD COLLECTION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 PEN NEEDLES
TABLE 15 EXAMPLES OF PEN NEEDLES
TABLE 16 PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 PEN NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.1 STANDARD NEEDLES
6.3.1.1 Standard pen needles preferred over safety pen needles as they are more affordable
TABLE 18 STANDARD PEN NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.2 SAFETY NEEDLES
6.3.2.1 Growing concerns over needlestick injuries to drive growth
TABLE 19 SAFETY PEN NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 SUTURE NEEDLES
6.4.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET
TABLE 20 EXAMPLES OF SUTURE NEEDLES
TABLE 21 SUTURE NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5 OPHTHALMIC NEEDLES
6.5.1 GROWING NUMBER OF BLOOD COLLECTION PROCEDURES TO DRIVE MARKET
TABLE 22 EXAMPLES OF OPHTHALMIC NEEDLES
TABLE 23 OPHTHALMIC NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6 DENTAL NEEDLES
6.6.1 MOST COMMONLY MADE OF STAINLESS STEEL
TABLE 24 EXAMPLES OF DENTAL NEEDLES
TABLE 25 DENTAL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7 INSUFFLATION NEEDLES
6.7.1 GROWING NUMBER OF MINIMALLY INVASIVE PROCEDURES TO BOOST MARKET GROWTH
TABLE 26 EXAMPLES OF INSUFFLATION NEEDLES
TABLE 27 INSUFFLATION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8 ASPIRATION AND BIOPSY NEEDLES
TABLE 28 EXAMPLES OF ASPIRATION AND BIOPSY NEEDLES
TABLE 29 ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 30 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8.1 BIOPSY NEEDLES
TABLE 31 BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 32 BIOPSY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8.1.1 Core biopsy needles
6.8.1.1.1 Widely used for sample collection in most prevalent cancer types
TABLE 33 CORE BIOPSY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8.1.2 Vacuum-assisted biopsy needles
6.8.1.2.1 High-volume sampling and greater specificity of VAB procedures to drive growth
TABLE 34 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8.2 ASPIRATION NEEDLES
6.8.2.1 Cost-effectiveness of needles to support market growth
TABLE 35 ASPIRATION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9 OTHER NEEDLES
TABLE 36 OTHER NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
7 NEEDLES MARKET, BY DELIVERY MODE (Page No. - 81)
7.1 INTRODUCTION
TABLE 37 NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
7.2 HYPODERMIC NEEDLES
7.2.1 FASTEST-GROWING DELIVERY MODE SEGMENT
TABLE 38 HYPODERMIC NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3 INTRAVENOUS NEEDLES
7.3.1 INCREASING DEMAND FOR VACCINES TO BOOST MARKET GROWTH
TABLE 39 INTRAVENOUS NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
7.4 INTRAMUSCULAR NEEDLES
7.4.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
TABLE 40 INTRAMUSCULAR NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
7.5 INTRAPERITONEAL NEEDLES
7.5.1 RISING NUMBER OF OVARIAN CANCER CASES TO DRIVE ADOPTION OF INTRAPERITONEAL NEEDLES
TABLE 41 INTRAPERITONEAL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
8 NEEDLES MARKET, BY TYPE (Page No. - 86)
8.1 INTRODUCTION
TABLE 42 NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.2 CONVENTIONAL NEEDLES
TABLE 43 CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 44 CONVENTIONAL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2.1 BEVEL NEEDLES
8.2.1.1 Bevel needles to dominate market in 2022
TABLE 45 BEVEL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2.2 BLUNT FILL NEEDLES
8.2.2.1 Increasing prevalence of needlestick injuries to drive market
TABLE 46 BLUNT FILL NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2.3 VENTED NEEDLES
8.2.3.1 Increasing focus on vaccination to boost market growth
TABLE 47 VENTED NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2.4 FILTER NEEDLES
8.2.4.1 Increasing usage for medication administration
TABLE 48 FILTER NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3 SAFETY NEEDLES
TABLE 49 SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 SAFETY NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3.1 ACTIVE NEEDLES
8.3.1.1 Largest and fastest-growing segment of safety needles market
TABLE 51 ACTIVE NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3.2 PASSIVE NEEDLES
8.3.2.1 Increasing prevalence of chronic diseases to drive market growth
TABLE 52 PASSIVE NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
9 NEEDLES MARKET, BY MATERIAL (Page No. - 94)
9.1 INTRODUCTION
TABLE 53 NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
9.2 STAINLESS STEEL/METALLIC NEEDLES
9.2.1 WIDESPREAD USE IN MEDICAL AND RESEARCH APPLICATIONS
TABLE 54 EXAMPLES OF STAINLESS STEEL/METALLIC NEEDLES
TABLE 55 STAINLESS STEEL/METALLIC NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3 GLASS NEEDLES
9.3.1 INCREASED APPLICATION IN DRUG DELIVERY TO DRIVE GROWTH
TABLE 56 GLASS NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
9.4 PLASTIC NEEDLES
9.4.1 ISSUES ASSOCIATED WITH GLASS NEEDLES TO DRIVE ADOPTION OF PLASTIC NEEDLES
TABLE 57 PLASTIC NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
9.5 POLYETHERETHERKETONE (PEEK) NEEDLES
9.5.1 APPLICATION OF PEEK NEEDLES IN WIDE RANGE OF SURGERIES AND PROCEDURES TO DRIVE GROWTH
TABLE 58 EXAMPLES OF PEEK NEEDLES
TABLE 59 PEEK NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
10 NEEDLES MARKET, BY APPLICATION (Page No. - 100)
10.1 INTRODUCTION
TABLE 60 NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.2 DIAGNOSTICS
10.2.1 LARGEST AND FASTEST-GROWING APPLICATION SEGMENT
TABLE 61 NEEDLES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
10.3 THERAPEUTICS
10.3.1 RISING PREVALENCE OF DISEASES TO DRIVE MARKET
TABLE 62 NEEDLES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
11 NEEDLES MARKET, BY END USER (Page No. - 103)
11.1 INTRODUCTION
TABLE 63 NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2 HOSPITALS
11.2.1 HIGH VOLUME OF BLOOD TRANSFUSIONS CONDUCTED IN HOSPITALS TO SUPPORT MARKET GROWTH
TABLE 64 NEEDLES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
11.3 DIAGNOSTIC CENTERS
11.3.1 INCREASING NUMBER OF DIAGNOSTIC TESTS TO DRIVE ADOPTION OF NEEDLES
TABLE 65 NEEDLES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2020–2027 (USD MILLION)
11.4 HOME HEALTHCARE
11.4.1 INCREASING USE OF INJECTIONS IN HOME CARE FOR MANAGEMENT OF CHRONIC DISEASES TO DRIVE MARKET
TABLE 66 NEEDLES MARKET FOR HOME HEALTHCARE, BY REGION, 2020–2027 (USD MILLION)
11.5 OTHER END USERS
TABLE 67 NEEDLES MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
12 NEEDLES MARKET, BY REGION (Page No. - 109)
12.1 INTRODUCTION
TABLE 68 NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: NEEDLES MARKET SNAPSHOT
TABLE 69 NORTH AMERICA: NEEDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 NORTH AMERICA: SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 NORTH AMERICA: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 NORTH AMERICA: BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 NORTH AMERICA: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 78 NORTH AMERICA: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 79 NORTH AMERICA: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 80 NORTH AMERICA: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.2.1 US
12.2.1.1 US dominates North American needles market
TABLE 81 US: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 US: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 83 US: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 84 US: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 85 US: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 86 US: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.2.2 CANADA
12.2.2.1 High prevalence of diseases in Canada to support market growth
TABLE 87 CANADA: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 CANADA: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 89 CANADA: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 90 CANADA: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 91 CANADA: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 92 CANADA: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.3 EUROPE
TABLE 93 EUROPE: NEEDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 94 EUROPE: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 EUROPE: CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 EUROPE: SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 EUROPE: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 98 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 EUROPE: BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 EUROPE: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 102 EUROPE: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 103 EUROPE: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 EUROPE: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.3.1 GERMANY
12.3.1.1 Largest and fastest-growing market for needles in Europe
TABLE 105 GERMANY: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 GERMANY: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 107 GERMANY: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 108 GERMANY: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 109 GERMANY: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 110 GERMANY: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.3.2 FRANCE
12.3.2.1 Rising need for blood components to support market growth
TABLE 111 FRANCE: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 FRANCE: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 113 FRANCE: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 114 FRANCE: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 115 FRANCE: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 116 FRANCE: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.3.3 UK
12.3.3.1 Increasing incidence of cancer to drive market growth
TABLE 117 UK: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 UK: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 119 UK: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 120 UK: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 121 UK: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 122 UK: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.3.4 SPAIN
12.3.4.1 Growing road accidents to drive market
TABLE 123 SPAIN: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 SPAIN: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 125 SPAIN: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 126 SPAIN: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 127 SPAIN: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 128 SPAIN: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.3.5 ITALY
12.3.5.1 Increasing number of blood donations to drive adoption of needles
TABLE 129 ITALY: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 ITALY: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 131 ITALY: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 132 ITALY: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 133 ITALY: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 134 ITALY: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.3.6 REST OF EUROPE
TABLE 135 REST OF EUROPE: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 REST OF EUROPE: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 137 REST OF EUROPE: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 138 REST OF EUROPE: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 139 REST OF EUROPE: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 140 REST OF EUROPE: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: NEEDLES MARKET SNAPSHOT
TABLE 141 ASIA PACIFIC: NEEDLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 142 ASIA PACIFIC: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 ASIA PACIFIC: CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 ASIA PACIFIC: SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 ASIA PACIFIC: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 146 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 ASIA PACIFIC: BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 ASIA PACIFIC: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 150 ASIA PACIFIC: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 151 ASIA PACIFIC: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 152 ASIA PACIFIC: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.4.1 CHINA
12.4.1.1 Increasing number of surgical procedures to drive market
TABLE 153 CHINA: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 CHINA: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 155 CHINA: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 156 CHINA: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 157 CHINA: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 158 CHINA: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Rising geriatric population to drive market
TABLE 159 JAPAN: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 JAPAN: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 161 JAPAN: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 162 JAPAN: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 163 JAPAN: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 164 JAPAN: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Rising demand for innovative technologies to support market growth
TABLE 165 INDIA: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 INDIA: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 167 INDIA: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 168 INDIA: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 169 INDIA: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 170 INDIA: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.4.4 REST OF ASIA PACIFIC
TABLE 171 REST OF ASIA PACIFIC: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 175 REST OF ASIA PACIFIC: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
12.5 REST OF THE WORLD
TABLE 177 REST OF THE WORLD: NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 REST OF THE WORLD: CONVENTIONAL NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 REST OF THE WORLD: SAFETY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 REST OF THE WORLD: NEEDLES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 181 REST OF THE WORLD: PEN NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 REST OF THE WORLD: ASPIRATION AND BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 REST OF THE WORLD: BIOPSY NEEDLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 REST OF THE WORLD: NEEDLES MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
TABLE 185 REST OF THE WORLD: NEEDLES MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
TABLE 186 REST OF THE WORLD: NEEDLES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 187 REST OF THE WORLD: NEEDLES MARKET, BY END USER, 2020–2027 (USD MILLION)
13 COMPETITIVE LANDSCAPE (Page No. - 163)
13.1 OVERVIEW
13.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 188 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NEEDLES MARKET
13.3 REVENUE SHARE ANALYSIS
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN NEEDLES MARKET
13.4 MARKET SHARE ANALYSIS
TABLE 189 NEEDLES MARKET: DEGREE OF COMPETITION
13.5 COMPANY EVALUATION MATRIX
13.5.1 STARS
13.5.2 PERVASIVE PLAYERS
13.5.3 EMERGING LEADERS
13.5.4 PARTICIPANTS
FIGURE 29 NEEDLES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS
13.6 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
FIGURE 30 NEEDLES MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS
13.7 COMPANY FOOTPRINT ANALYSIS
13.7.1 REGIONAL FOOTPRINT OF COMPANIES
13.7.2 PRODUCT FOOTPRINT OF COMPANIES
13.7.3 OVERALL FOOTPRINT OF COMPANIES
13.8 COMPETITIVE SCENARIO
13.8.1 PRODUCT LAUNCHES
TABLE 190 KEY PRODUCT LAUNCHES
13.8.2 DEALS
TABLE 191 KEY DEALS
13.8.3 OTHER DEVELOPMENTS
TABLE 192 OTHER KEY DEVELOPMENTS
14 COMPANY PROFILES (Page No. - 173)
(Business overview, Products offered, Recent developments & MnM View)*
14.1 KEY PLAYERS
14.1.1 BECTON, DICKINSON AND COMPANY
TABLE 193 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
14.1.2 HAMILTON COMPANY
TABLE 194 HAMILTON COMPANY: BUSINESS OVERVIEW
14.1.3 MEDTRONIC PLC
TABLE 195 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 32 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
14.1.4 B. BRAUN MELSUNGEN
TABLE 196 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW
FIGURE 33 B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2021)
14.1.5 STRYKER
TABLE 197 STRYKER: BUSINESS OVERVIEW
FIGURE 34 STRYKER: COMPANY SNAPSHOT (2021)
14.1.6 ETHICON (SUBSIDIARY OF JOHNSON & JOHNSON)
TABLE 198 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 35 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
14.1.7 BOSTON SCIENTIFIC CORPORATION
TABLE 199 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021)
14.1.8 UNIMED SA
TABLE 200 UNIMED SA: BUSINESS OVERVIEW
14.1.9 TERUMO CORPORATION
TABLE 201 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 37 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
14.1.10 OLYMPUS CORPORATION
TABLE 202 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
14.1.11 NIPRO CORPORATION
TABLE 203 NIPRO CORPORATION: BUSINESS OVERVIEW
FIGURE 39 NIPRO CORPORATION: COMPANY SNAPSHOT (2021)
14.1.12 ARGON MEDICAL DEVICES INC.
TABLE 204 ARGON MEDICAL DEVICES, INC.: BUSINESS OVERVIEW
14.1.13 MERCK KGAA
TABLE 205 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2021)
14.1.14 MERIT MEDICAL SYSTEMS
TABLE 206 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2021)
14.1.15 GREINER HOLDING AG
TABLE 207 GREINER HOLDING AG: BUSINESS OVERVIEW
FIGURE 42 GREINER HOLDING: COMPANY SNAPSHOT (2021)
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
14.2 OTHER COMPANIES
14.2.1 SMITHS MEDICAL (NOW ICU MEDICAL)
14.2.2 ULTIMED, INC.
14.2.3 HAKKO CO., LTD.
14.2.4 CREGANNA
14.2.5 DTR MEDICAL
14.2.6 ROCKET MEDICAL PLC
15 APPENDIX (Page No. - 212)
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the Needles Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons) and supply sides (Needle manufacturers and distributors).
The following is a breakdown of the primary respondents:
Breakdown of Primary Participants:
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 =
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the Needles Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Needle Market industry.
Report Objectives
- To define, describe, and forecast the global Needle Market based on Product, Type, Application, Material, Delivery Mode, End User and Region.
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Needle Market.
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
- Geographic Analysis: Further breakdown of the European Needle Market into specific countries.
Generating Response ...
Growth opportunities and latent adjacency in Needles Market